A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Salivary Gland Cancer Bookmark and Share

Salivary Gland Cancer

City of Hope offers a truly comprehensive treatment approach to salivary gland cancer. We employ the latest chemotherapy protocols and develop promising experimental therapies through our drug development research programs. These combined attributes allow us to provide powerful therapeutic options to patients fighting salivary gland cancer.

Salivary gland cancer patients at City of Hope receive treatment from a coordinated, multidisciplinary team of surgeons, oncologists, endocrinologists, radiation oncologists, nurses, supportive care specialists and others, ensuring the highest possible standard of care.
 
About Salivary Gland Cancer
 
The term “salivary gland cancer” represents a diverse group of malignant tumors. These tumors may occur in different types of salivary glands and originate from a variety of cell types. These characteristics impact prognosis and treatment options.

Types of Salivary Glands

Salivary glands are classified as major or minor. The major salivary glands come in pairs, and are much larger than the minor salivary glands. The major salivary glands are:

  • Parotid glands - the largest of the salivary glands, located immediately in front of and below each ear
  • Sublingual glands –these glands are located under the tongue
  • Submandibular glands – these glands are located beneath the mandible, or jawbone.
 
The minor salivary glands are very small, and are located in the mucosa (mucous membranes) of the lips and cheeks, hard and soft palate, uvula, the floor of the mouth, the back of the tongue, and the area near the tonsils, among other areas of the mouth and throat. Most tumors of the minor salivary glands are located in the hard palate, which has the greatest concentration of minor salivary glands in the mouth.
 
Salivary Gland Cancer Risk Factors
 
  • Age: Most patients are diagnosed in their 50s and 60s
  • External radiation exposure, especially to the head and neck; this includes radiation therapy used in previous cancer treatment
  • Tobacco use – both smoking and chewing tobacco may increase the risk of squamous cell salivary cancers
  • Occupational exposure – workers exposed to silica dust, nickel-containing dust, asbestos, as well as those engaged in rubber products manufacturing, plumbing and some types of woodworking may be more likely to develop salivary cancer
  • Family history of salivary gland cancer
  • Diet – some studies suggest a diet high in animal fats and low in vegetables may increase the risk of salivary gland cancer
 
Salivary Gland Cancer Symptoms
 
Salivary gland cancer may not cause any symptoms. It is sometimes found during a regular dental check-up or physical exam. Symptoms caused by salivary gland cancer also may be caused by other conditions.

Symptoms specific or more common to a particular type of salivary gland cancer are mentioned in the descriptions of each type of cancer, listed above. A doctor should be consulted if any of the following problems occur:
 
  • A lump (usually painless) in the area of the ear, cheek, jaw, lip or inside the mouth
  • Fluid draining from the ear
  • Trouble swallowing or opening the mouth widely
  • Numbness or weakness in the face
  • Pain in the face that does not go away

Salivary Gland Cancer Staging

Staging is the process of finding out if and how far a cancer has spread. The stage of a cancer is one of the most important factors in choosing treatment options and predicting your chance for cure and long-term survival.

Staging is based on the results of the physical exam, biopsy, the physician’s impression during or after surgery to remove the tumor (presence or absence of invasion of the tumor to other organs) and imaging tests (ultrasound, computed tomography scan, magnetic resonance imaging, positron emission tomography scan or endoscopy).

Stage I
In stage I, the tumor is in the salivary gland only and is 2 centimeters or smaller.

Stage II
In stage II, the tumor is in the salivary gland only and is larger than 2 centimeters but not larger than 4 centimeters.

Stage III
In stage III, one of the following is true:

The tumor is not larger than 4 centimeters and has spread to a single lymph node on the same side as the tumor and the lymph node is 3 centimeters or smaller.

The tumor is larger than 4 centimeters and/or has spread to soft tissue around the affected gland. Cancer may have spread to a single lymph node on the same side as the tumor and the lymph node is 3 centimeters or smaller.

Stage IV
Stage IV is divided into stages IVA, IVB and IVC as follows:

Stage IVA:
The tumor may be any size and may have spread to soft tissue around the affected gland. Cancer has spread to one or more lymph nodes on either or both sides of the body and the lymph nodes are not larger than 6 centimeters; or

Cancer has spread to the skin, jawbone, ear canal and/or facial nerve, and may have spread to one or more lymph nodes on either or both sides of the body. The lymph nodes are not larger than 6 centimeters.

Stage IVB:
The tumor may be any size and may have spread to soft tissue around the affected gland. Cancer has spread to a lymph node larger than 6 centimeters; or

Cancer has spread to the base of the skull and/or the carotid artery, and may have spread to one or more lymph nodes of any size on either or both sides of the body.

Stage IVC:
The tumor may be any size and may have spread to soft tissue around the affected gland, to the skin, jawbone, ear canal, facial nerve, base of the skull or carotid artery, or to one or more lymph nodes on either or both sides of the body. Cancer has spread to distant parts of the body.

Salivary gland cancers are also grouped by grade. The grade of a tumor describes how fast the cancer cells are growing based on how the cells look under a microscope. Low-grade cancers grow more slowly than high-grade cancers.

Minor salivary gland cancers are staged according to where they were first found in the body.

Diagnosing Salivary Gland Cancer

A variety of methods is used to diagnose salivary gland cancer. They include:
 

  • Physical exam and history
After a physical exam that reveals cause for suspicion of salivary gland cancer, imaging tests may be ordered to determine the extent of spread of the tumor, if any. Standard imaging tests include:
 

 

  • Magnetic resonance imaging (MRI): A procedure that uses a magnet, radio waves and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear MRI , or NMRI.
  • CT (computed tomography) scan: A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an X-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computerized tomography or computerized axial tomography.
  • Positron emission tomography (PET) scan: A procedure to find malignant tumor cells in the body. A small amount of a radioactive glucose derivative (fluorodeoxyglucose) is injected into a vein. The PET scanner rotates around the body and generates a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.
  • Ultrasound exam: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram.
  • Endoscopy: A procedure to look at organs and tissues inside the body to check for abnormal areas. For salivary gland cancer, an endoscope is inserted into the mouth to look at the mouth, throat and larynx. An endoscope is a thin, tube-like instrument with a light and a lens for viewing.


After identifying the primary site or sites of the tumor, a biopsy may be ordered, as detailed below:
 

  • Fine needle aspiration biopsy: The removal of tissue or fluid using a thin needle. A pathologist views the tissue or fluid under a microscope to look for cancer cells. This test is necessary to establish three things: 1) whether the tumor is benign or malignant, 2) what type of cell the tumor originated from and 3) what grade, or level of differentiation, the tumor cells display.
 

Salivary Gland Cancer Treatment Approaches

Surgery
First-line treatment for salivary gland cancer is surgery.  The surgeon will remove the affected salivary gland and possibly some surrounding tissue.  If nearby lymph nodes are thought to be involved, they will also be removed, and a neck dissection will be performed.
 
Radiation Therapy
In cases of higher-grade or larger tumors, unclean surgical margins or evidence of lymph node metastasis, postoperative radiation therapy is recommended to improve clinical outcomes. It may be used by itself in cases where the tumor may be too large to be removed surgically, where surgery would be disfiguring, or if the tumor is inoperable for other reasons. It is useful for reducing symptoms such as pain and difficulty in swallowing.
 
City of Hope’s Radiation Oncology was the first in the western United States to offer the helical TomoTherapy Hi-Art System, one of the first radiation therapy systems of its kind to incorporate not only radiation therapy, but also tumor imaging capabilities comparable to a diagnostic computed tomography (CT) scan.
 
Radiation therapy is a localized treatment, which means it provides benefits — and side effects — in the exact area where it’s delivered.  By reducing the radiation dose to an area of normal, healthy tissue, a patient will experience potentially fewer side effects than they would in a more conventional treatment setting. This is especially important in the treatment of cancers of the head and neck region.  If the radiation dose can be spared to any portion of the oral cavity (mouth) or throat, the patient will experience significant fewer problems in making their way through the course of treatment. This advanced technique makes it possible to reduce the dose to the parotid gland, hence – saliva is preserved – lessening a patient’s possibility of having a dry mouth.  In addition, TomoTherapy can assist in reducing dose to the normal swallowing muscles.  This can improve a patient’s ability to continue eating – directly impacting a patient’s quality of life.
 
Chemotherapy
Chemotherapy is sometimes used with radiation in cases of salivary gland cancer where the disease is metastatic, unresectable and/or recurrent.  It may also be employed postsurgically (along with radiation) in late-stage or aggressive cancers. Chemotherapy regimens vary depending on the particular cell type in question.
 
Clinical Trials
City of Hope has several clinical trials involving experimental therapies for advanced solid tumors of the head and neck. Some of these may apply to salivary cancer.  One clinical trial includes the use of cetuximab (Erbitux), a monoclonal antibody that inhibits EGFR (epidermal growth factor receptor), impairing the growth of cancer cells. Sometimes, this is combined with radiation and chemotherapy.  Click here for more information.
 
Follow-up
Because salivary gland cancer can recur, patients should be followed closely for any signs of recurrence or metastasis. This is accomplished by regular physical exams that include thorough head and neck palpation as well as multiple imaging modalities, e.g., ultrasound, CT, magnetic resonance imaging and positron emission tomography scans.
 

Salivary Gland Cancer Team

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts over 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Development Officer
Phone: 626-218-6250
Email: jmorgan@coh.org

 
 

Salivary Gland Cancer

Salivary Gland Cancer

City of Hope offers a truly comprehensive treatment approach to salivary gland cancer. We employ the latest chemotherapy protocols and develop promising experimental therapies through our drug development research programs. These combined attributes allow us to provide powerful therapeutic options to patients fighting salivary gland cancer.

Salivary gland cancer patients at City of Hope receive treatment from a coordinated, multidisciplinary team of surgeons, oncologists, endocrinologists, radiation oncologists, nurses, supportive care specialists and others, ensuring the highest possible standard of care.
 
About Salivary Gland Cancer
 
The term “salivary gland cancer” represents a diverse group of malignant tumors. These tumors may occur in different types of salivary glands and originate from a variety of cell types. These characteristics impact prognosis and treatment options.

Types of Salivary Glands

Salivary glands are classified as major or minor. The major salivary glands come in pairs, and are much larger than the minor salivary glands. The major salivary glands are:

  • Parotid glands - the largest of the salivary glands, located immediately in front of and below each ear
  • Sublingual glands –these glands are located under the tongue
  • Submandibular glands – these glands are located beneath the mandible, or jawbone.
 
The minor salivary glands are very small, and are located in the mucosa (mucous membranes) of the lips and cheeks, hard and soft palate, uvula, the floor of the mouth, the back of the tongue, and the area near the tonsils, among other areas of the mouth and throat. Most tumors of the minor salivary glands are located in the hard palate, which has the greatest concentration of minor salivary glands in the mouth.
 
Salivary Gland Cancer Risk Factors
 
  • Age: Most patients are diagnosed in their 50s and 60s
  • External radiation exposure, especially to the head and neck; this includes radiation therapy used in previous cancer treatment
  • Tobacco use – both smoking and chewing tobacco may increase the risk of squamous cell salivary cancers
  • Occupational exposure – workers exposed to silica dust, nickel-containing dust, asbestos, as well as those engaged in rubber products manufacturing, plumbing and some types of woodworking may be more likely to develop salivary cancer
  • Family history of salivary gland cancer
  • Diet – some studies suggest a diet high in animal fats and low in vegetables may increase the risk of salivary gland cancer
 
Salivary Gland Cancer Symptoms
 
Salivary gland cancer may not cause any symptoms. It is sometimes found during a regular dental check-up or physical exam. Symptoms caused by salivary gland cancer also may be caused by other conditions.

Symptoms specific or more common to a particular type of salivary gland cancer are mentioned in the descriptions of each type of cancer, listed above. A doctor should be consulted if any of the following problems occur:
 
  • A lump (usually painless) in the area of the ear, cheek, jaw, lip or inside the mouth
  • Fluid draining from the ear
  • Trouble swallowing or opening the mouth widely
  • Numbness or weakness in the face
  • Pain in the face that does not go away

Salivary Gland Cancer Staging

Salivary Gland Cancer Staging

Staging is the process of finding out if and how far a cancer has spread. The stage of a cancer is one of the most important factors in choosing treatment options and predicting your chance for cure and long-term survival.

Staging is based on the results of the physical exam, biopsy, the physician’s impression during or after surgery to remove the tumor (presence or absence of invasion of the tumor to other organs) and imaging tests (ultrasound, computed tomography scan, magnetic resonance imaging, positron emission tomography scan or endoscopy).

Stage I
In stage I, the tumor is in the salivary gland only and is 2 centimeters or smaller.

Stage II
In stage II, the tumor is in the salivary gland only and is larger than 2 centimeters but not larger than 4 centimeters.

Stage III
In stage III, one of the following is true:

The tumor is not larger than 4 centimeters and has spread to a single lymph node on the same side as the tumor and the lymph node is 3 centimeters or smaller.

The tumor is larger than 4 centimeters and/or has spread to soft tissue around the affected gland. Cancer may have spread to a single lymph node on the same side as the tumor and the lymph node is 3 centimeters or smaller.

Stage IV
Stage IV is divided into stages IVA, IVB and IVC as follows:

Stage IVA:
The tumor may be any size and may have spread to soft tissue around the affected gland. Cancer has spread to one or more lymph nodes on either or both sides of the body and the lymph nodes are not larger than 6 centimeters; or

Cancer has spread to the skin, jawbone, ear canal and/or facial nerve, and may have spread to one or more lymph nodes on either or both sides of the body. The lymph nodes are not larger than 6 centimeters.

Stage IVB:
The tumor may be any size and may have spread to soft tissue around the affected gland. Cancer has spread to a lymph node larger than 6 centimeters; or

Cancer has spread to the base of the skull and/or the carotid artery, and may have spread to one or more lymph nodes of any size on either or both sides of the body.

Stage IVC:
The tumor may be any size and may have spread to soft tissue around the affected gland, to the skin, jawbone, ear canal, facial nerve, base of the skull or carotid artery, or to one or more lymph nodes on either or both sides of the body. Cancer has spread to distant parts of the body.

Salivary gland cancers are also grouped by grade. The grade of a tumor describes how fast the cancer cells are growing based on how the cells look under a microscope. Low-grade cancers grow more slowly than high-grade cancers.

Minor salivary gland cancers are staged according to where they were first found in the body.

Diagnosing Salivary Gland Cancer

Diagnosing Salivary Gland Cancer

A variety of methods is used to diagnose salivary gland cancer. They include:
 

  • Physical exam and history
After a physical exam that reveals cause for suspicion of salivary gland cancer, imaging tests may be ordered to determine the extent of spread of the tumor, if any. Standard imaging tests include:
 

 

  • Magnetic resonance imaging (MRI): A procedure that uses a magnet, radio waves and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear MRI , or NMRI.
  • CT (computed tomography) scan: A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an X-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computerized tomography or computerized axial tomography.
  • Positron emission tomography (PET) scan: A procedure to find malignant tumor cells in the body. A small amount of a radioactive glucose derivative (fluorodeoxyglucose) is injected into a vein. The PET scanner rotates around the body and generates a picture of where glucose is being used in the body. Malignant tumor cells show up brighter in the picture because they are more active and take up more glucose than normal cells do.
  • Ultrasound exam: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram.
  • Endoscopy: A procedure to look at organs and tissues inside the body to check for abnormal areas. For salivary gland cancer, an endoscope is inserted into the mouth to look at the mouth, throat and larynx. An endoscope is a thin, tube-like instrument with a light and a lens for viewing.


After identifying the primary site or sites of the tumor, a biopsy may be ordered, as detailed below:
 

  • Fine needle aspiration biopsy: The removal of tissue or fluid using a thin needle. A pathologist views the tissue or fluid under a microscope to look for cancer cells. This test is necessary to establish three things: 1) whether the tumor is benign or malignant, 2) what type of cell the tumor originated from and 3) what grade, or level of differentiation, the tumor cells display.
 

Salivary Gland Cancer Treatment Options

Salivary Gland Cancer Treatment Approaches

Surgery
First-line treatment for salivary gland cancer is surgery.  The surgeon will remove the affected salivary gland and possibly some surrounding tissue.  If nearby lymph nodes are thought to be involved, they will also be removed, and a neck dissection will be performed.
 
Radiation Therapy
In cases of higher-grade or larger tumors, unclean surgical margins or evidence of lymph node metastasis, postoperative radiation therapy is recommended to improve clinical outcomes. It may be used by itself in cases where the tumor may be too large to be removed surgically, where surgery would be disfiguring, or if the tumor is inoperable for other reasons. It is useful for reducing symptoms such as pain and difficulty in swallowing.
 
City of Hope’s Radiation Oncology was the first in the western United States to offer the helical TomoTherapy Hi-Art System, one of the first radiation therapy systems of its kind to incorporate not only radiation therapy, but also tumor imaging capabilities comparable to a diagnostic computed tomography (CT) scan.
 
Radiation therapy is a localized treatment, which means it provides benefits — and side effects — in the exact area where it’s delivered.  By reducing the radiation dose to an area of normal, healthy tissue, a patient will experience potentially fewer side effects than they would in a more conventional treatment setting. This is especially important in the treatment of cancers of the head and neck region.  If the radiation dose can be spared to any portion of the oral cavity (mouth) or throat, the patient will experience significant fewer problems in making their way through the course of treatment. This advanced technique makes it possible to reduce the dose to the parotid gland, hence – saliva is preserved – lessening a patient’s possibility of having a dry mouth.  In addition, TomoTherapy can assist in reducing dose to the normal swallowing muscles.  This can improve a patient’s ability to continue eating – directly impacting a patient’s quality of life.
 
Chemotherapy
Chemotherapy is sometimes used with radiation in cases of salivary gland cancer where the disease is metastatic, unresectable and/or recurrent.  It may also be employed postsurgically (along with radiation) in late-stage or aggressive cancers. Chemotherapy regimens vary depending on the particular cell type in question.
 
Clinical Trials
City of Hope has several clinical trials involving experimental therapies for advanced solid tumors of the head and neck. Some of these may apply to salivary cancer.  One clinical trial includes the use of cetuximab (Erbitux), a monoclonal antibody that inhibits EGFR (epidermal growth factor receptor), impairing the growth of cancer cells. Sometimes, this is combined with radiation and chemotherapy.  Click here for more information.
 
Follow-up
Because salivary gland cancer can recur, patients should be followed closely for any signs of recurrence or metastasis. This is accomplished by regular physical exams that include thorough head and neck palpation as well as multiple imaging modalities, e.g., ultrasound, CT, magnetic resonance imaging and positron emission tomography scans.
 

Salivary Gland Cancer Team

Salivary Gland Cancer Team

Support This Program

Support this program

We deliver exquisite care at the leading edge of cancer treatment. It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts over 100 years ago. Their efforts - and those of our supporters today - have built the foundation for the care we provide and the research we conduct. It enables City of Hope to strive for new breakthroughs and better therapies - helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact:

Janet Morgan

Senior Development Officer
Phone: 626-218-6250
Email: jmorgan@coh.org

 
 
Quick Links
With Cancer, Expertise Matters

 
Cancer patients need to have confidence in their treatment plans by exploring all possible options. Often that means they should get a second opinion. For these four patients, getting a second opinion from experts at City of Hope was life-saving.
Supportive Care Calendar
 
With MyCityofHope your health information is right at your fingertips, anywhere, any time.


NEWS & UPDATES
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...
  • Sure, a healthy lifestyle can lower a person’s risk, but the impact of specific actions is harder to tease out. Diet, exercise, tobacco use, nutritional supplements, alcohol consumption … How important are each of these factors, individually? Does strict adherence to (or rejection of) one get you a pass o...
  • Health care decisions are tough. They’re even tougher when you – or loved ones – have to make them without a plan or a conversation. National Healthcare Decisions Day, on April 16,  is a nationwide initiative to demystify the health care decision-making process and encourage families to start talking. Ult...
  • The statistics, direct from the American Cancer Society, are sobering: Cancer death rates among African-American men are 27 percent higher than for white men. The death rate for African-American women is 11 percent higher compared to white women. Hispanics have higher rates of cervical, liver and stomach cancer...
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...
  • Neural stem cells have a natural ability to seek out cancer cells in the brain. Recent research from the laboratories of Michael Barish, Ph.D., and Karen Aboody, M.D., may offer a new explanation for this attraction between stem cells and tumors. Prior to joining City of Hope, Aboody, now a professor in the Dep...
  • The American Society of Clinical Oncology, a group that includes more than 40,000 cancer specialists around the country, recently issued a list of the five most profound cancer advances over the past five decades. Near the top of the list was the introduction of chemotherapy for testicular cancer. To many in th...
  • “The dying, as a group, have been horribly underserved.” So says Bonnie Freeman, R.N., D.N.P., A.N.P.-B.C., A.C.H.P.N., a nurse practitioner in the Department of Supportive Care Medicine at City of Hope. After nearly 25 years, primarily in critical care nursing, Freeman saw that the needs of the dying were ofte...
  • “Are we the only ones who feel this way?” Courtney Bitz, L.C.S.W., a social worker in the Sheri & Les Biller Patient and Family Resource Center at City of Hope, often hears this question from couples trying to cope with a breast cancer diagnosis and still keep their relationship strong. The ques...
  • Diabetes investigators at City of Hope are studying the full trajectory of diabetes and metabolic disorders, as well as complications of the disease. One especially promising approach focuses on proteins known as growth factors. Led by Fouad Kandeel, M.D., Ph.D., chair and professor of the Department of Clinica...
  • Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades ago, in 1996, the National Comprehensive Cancer Network (NCCN) published its first guidelines for treatment of acute myeloid leukemia, or AML. Margaret O’Donnell, M.D., assoc...
  • Children diagnosed with cancer are more likely than ever before to survive the disease, but with a potential new set of health problems caused by the cancer treatment itself. Those problems can particularly affect the heart, and as doctors and other health care workers try to assess how best to care for this sp...
  • Karen Reckamp, M.D., M.S., has an office next to my own, and we often see patients at the same time. As such, I’ve gotten to know her quite well over the years, and I’ve also gotten a glimpse of many of her patients. She specializes in lung cancer, and most of her patients have tumors […]